Next, to examine whether IL-33 could provoke enhanced IL-6 expression in primary AML samples, we treated BM and PB cells with IL-33 or in combination with anti-IL-33 antibody for 72 h in culture and determined IL-6 expression. The gene discussed is IL33; the disease is acute myeloid leukemia.